Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 21 Issue 5, May 2003

Editorial

Top of page ⤴

Business and Regulatory News

Top of page ⤴

Commentary

Top of page ⤴

Fools Corner

Top of page ⤴

Book Review

Top of page ⤴

Correspondence

Top of page ⤴

Feature

  • Regulatory agencies are being pulled in several directions at once, and drug developers must learn to adapt swiftly to a rapidly changing landscape.

    • Alan Dove
    Feature
  • Because life scientists are now using the Web not only for information gathering, but also for e-commerce, bio-portals business plans are looking more tenable.

    • Robert M. Frederickson
    Feature
Top of page ⤴

News & Views

  • The completion of the sequence of a second Streptomyces chromosome further establishes these soil-dwelling bacteria as nature's most prolific producers of potentially useful pharmaceuticals.

    • David A. Hopwood
    News & Views
  • Tissue engineers have developed a synthetic matrix that interacts with host cells to deliver bone-inductive proteins for bone regeneration.

    • John M. Wozney
    • Rebecca H. Li
    News & Views
  • A new mass spectrometry–based approach identifies and characterizes membrane proteins on a large scale.

    • Thierry Rabilloud
    News & Views
Top of page ⤴

News in Brief

Top of page ⤴

Article

Top of page ⤴

Technical Report

Top of page ⤴

Patents

Top of page ⤴

People

Top of page ⤴

New on the Market

Top of page ⤴

Careers and Recruitment

Top of page ⤴

Search

Quick links